Skip to content

ORCHARDS-AIR Study

ORegon CHild Absenteeism Due to Respiratory Disease Study - Air Surveillance

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07298967
Enrollment
422
Registered
2025-12-23
Start date
2026-01-07
Completion date
2027-06-01
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infection, Influenza-like Illness

Brief summary

The purpose of this observational study is to compare the effectiveness of air surveillance and to better understand the relationship between household transmission and viruses detected in the air. Participants will provide nasal swabs and have an air sample surveillance device installed in their home.

Detailed description

The purpose of ORCHARDS-AIR is to utilize air surveillance in participant homes in conjunction with individually collected nasal specimens to assess their concordance and evaluate the significance of airborne detection with household transmission of common respiratory pathogens such as influenza and SARS-CoV-2. The researchers postulate that households with documented and probable respiratory pathogen transmission will have higher rates of in-home air surveillance detection. Students with more severe illnesses will be absent more often and spend more time at home, potentially leading to absenteeism being associated with greater air surveillance detections and intrahousehold transmission.

Interventions

DIAGNOSTIC_TESTNasal swab

Participants will use a swab to collect nasal specimens

DEVICEIndoor air quality monitor

InBio Apollo ambient air sampler to be run in the home for the duration of study participation. Material from the air, like aerosols, dust particles, and other environmental material, are collected on sampler filler material.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- Students: * Student attends, or is eligible to attend, a school within the Oregon School District (OSD) * Study has an illness characterized by at least 2 of 6 acute respiratory infection (ARI)/ILI symptoms (nasal discharge, nasal congestion, sneezing, sore throat, cough, fever) and student scores at least 2 points on the Jackson scale

Exclusion criteria

- Students: * Household member listed on Wisconsin Department of Corrections Sex Offender Registry * Illness onset more than 7 days before anticipated time of specimen collection * Anatomical defect for which nasal specimen collection is contraindicated * Student participated too recently (\<7 days from day 14 during peak influenza / COVID-19 period and \<30 days during other times, as determined by a medically-attended surveillance program) Inclusion Criteria - Household member: * Live in the same household as eligible student participant * Any age and gender * Fluent in English * Able to provide appropriate consent or assent

Design outcomes

Primary

MeasureTime frameDescription
Rate of virus detectionDay 0, Day 7, Day 14Participants will provide nasal swabs, which will be tested for a panel of viruses.
Rate of air sampling detection among families with documented transmissionDay 7, Day 14Study team will collect and test air sampler filter for viruses.
Rate of air sampling detection among families without documented transmissionDay 7, Day 14Study team will collect and test air sampler filter for viruses.
Survey of symptoms - day 0Day 0Qualitative survey of participants' symptoms and related activities.
Survey of symptoms - day 7Day 7Qualitative survey of participants' symptoms and related activities.
Survey of symptoms - day 14Day 14Qualitative survey of participants' symptoms and related activities.
Air sampler use surveyDay 7, Day 14Qualitative survey about participants' use of the air sampler.

Secondary

MeasureTime frameDescription
Number of absences14 daysParticipants will self-report whether they were absent from school during the study period.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJonathan Temte, MD, PhD

University of Wisconsin, Madison

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026